Post-implantation syndrome following endovascular abdominal aortic aneurysm repair: preliminary data

Autor: Eleni Arnaoutoglou, George K. Papadopoulos, Nektario Papa, George Kouvelos, Nikolaos Kolaitis, Haralampos J. Milionis, Miltiadis Matsagkas, Anestis Mavridis
Rok vydání: 2011
Předmět:
Male
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Time Factors
Systemic Inflammatory Response Syndrome/blood/*etiology/immunology
medicine.medical_treatment
Pilot Projects
Blood Vessel Prosthesis Implantation/*adverse effects
Endovascular aneurysm repair
Blood Vessel Prosthesis Implantation
Aortic aneurysm
Humans
Medicine
Prospective Studies
Prospective cohort study
Aged
Aged
80 and over

Chi-Square Distribution
Greece
medicine.diagnostic_test
biology
business.industry
Endovascular Procedures
C-reactive protein
Complete blood count
Length of Stay
Middle Aged
medicine.disease
Endovascular Procedures/*adverse effects
Systemic Inflammatory Response Syndrome
Abdominal aortic aneurysm
Surgery
Treatment Outcome
Inflammation Mediators/blood
Aortic Aneurysm
Abdominal/*surgery

biology.protein
Female
Inflammation Mediators
Cardiology and Cardiovascular Medicine
business
Complication
Aortic Aneurysm
Abdominal

Abdominal surgery
Zdroj: Interactive CardioVascular and Thoracic Surgery. 12:609-614
ISSN: 1569-9293
DOI: 10.1510/icvts.2010.256784
Popis: OBJECTIVES: Endovascular aneurysm repair (EVAR), may elicit an unexpected systemic inflammatory response, which has been named post-implantation syndrome (PIS). The aim of this study was to prospectively evaluate the association of PIS with clinical and laboratory parameters in patients who underwent EVAR for abdominal aortic aneurysms (AAA). METHODS: Forty consecutive patients who underwent EVAR for AAA were studied. Complete blood count, fibrinogen, high sensitivity C-reactive protein (hs-CRP), interleukin (IL)-6, IL-1, tumor necrosis factor-alpha were determined before and after surgery. Several parameters regarding the operation, as well as the hospitalization days were recorded. RESULTS: PIS was diagnosed in 35% of the patients. Patients with PIS showed significant greater changes of inflammation marker levels, including hs-CRP and IL-6, as compared with the non-PIS group. PIS was associated with longer hospitalization. CONCLUSION: PIS is a relatively common complication of EVAR used to treat AAAs and it is associated with features of a systemic inflammatory response and prolongation of hospitalization. Further studies are necessary towards understanding the underlying pathophysiology and evaluating effective preventive strategies. Interact Cardiovasc Thorac Surg
Databáze: OpenAIRE